Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
2001 Standout
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
2013
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer
2007
The extracellular domain of Her2 in serum as a biomarker of breast cancer
2018
Herceptin: mechanisms of action and resistance
2005
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
A Comprehensive Review of Noninvasive Liver Fibrosis Tests in Pediatric Nonalcoholic Fatty Liver Disease
2015
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
2015 Standout
Xylosyltransferase II is the predominant isoenzyme which is responsible for the steady-state level of xylosyltransferase activity in human serum
2015 StandoutNobel
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
International Union of Pharmacology. XLIX. Nomenclature and Structure-Function Relationships of Transient Receptor Potential Channels
2005 StandoutNobel
Urine markers for detection and surveillance of bladder cancer
2013
Limitations of non-invasive tests for assessment of liver fibrosis
2020
Simple diffusion-constrained immunoassay for p24 protein with the sensitivity of nucleic acid amplification for detecting acute HIV infection
2012
Increased serum xylosyltransferase activity in patients with liver fibrosis
2009
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Ovarian cancer
2014 Standout
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
2004 Standout
Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer
2006
ThermoTRP channels and beyond: mechanisms of temperature sensation
2003 StandoutNobel
Timing of debulking surgery in advanced ovarian cancer
2008
Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network
2011
Imaging in the era of molecular oncology
2008 StandoutNature
Trastuzumab: triumphs and tribulations
2007
Performance of ELF Serum Markers in Predicting Fibrosis Stage in Pediatric Non-Alcoholic Fatty Liver Disease
2008
Psoriasis
2021 Standout
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
2008 Standout
Non-alcoholic fatty liver disease: The mist gradually clears
2008
Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study
1996
The NAFLD fibrosis score
2007 Standout
Non-alcoholic fatty liver disease
2021 Standout
International Union of Pharmacology. XLIII. Compendium of Voltage-Gated Ion Channels: Transient Receptor Potential Channels
2003 StandoutNobel
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
The golden age: gold nanoparticles for biomedicine
2011 Standout
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
2011 Standout
Secondary Surgical Cytoreduction for Advanced Ovarian Carcinoma
2004
Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease
2019
Bladder cancer
2016 Standout
Identification of a cold receptor reveals a general role for TRP channels in thermosensation
2002 StandoutNatureNobel
Transient Elastography for the Noninvasive Assessment of Liver Fibrosis: A Multicentre Canadian Study
2010
A TRP Channel that Senses Cold Stimuli and Menthol
2002 StandoutNobel
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers
2007
Integrated Nanoparticle–Biomolecule Hybrid Systems: Synthesis, Properties, and Applications
2004 Standout
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Does Neoadjuvant Chemotherapy Increase Optimal Cytoreduction Rate in Advanced Ovarian Cancer? Meta-Analysis of 21 Studies
2009
Cancer immunotherapy comes of age
2011 StandoutNature
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Advances in functional and molecular MRI technologies in chronic liver diseases
2020
Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: A meta-analysis
2006
Mechanical Stretch Induces Epithelial-Mesenchymal Transition in Alveolar Epithelia via Hyaluronan Activation of Innate Immunity
2011
Molecular MRI of collagen to diagnose and stage liver fibrosis
2013
A Bright Future for Precision Medicine: Advances in Fluorescent Chemical Probe Design and Their Clinical Application
2016
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
2008
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
2006 Standout
Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C†
2005
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Surface‐Enhanced Raman Spectroscopy: Concepts and Chemical Applications
2014 Standout
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
2010 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Ovarian cancer: Epidemiology, biology, and prognostic factors
2000
Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study
2004
Cancer of the Ovary
2004 Standout
Prediction of Response to Neoadjuvant Chemotherapy by Sequential F-18-Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced-Stage Ovarian Cancer
2005
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins.
2001
HER2 Testing in Breast Cancer: NCCN Task Force Report and Recommendations
2006
Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: The SHASTA index
2005
Noninvasive markers of hepatic fibrosis: Are they ready for prime time in the management of HIV/HCV co-infected patients?
2005
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
2013
Multilectin Affinity Chromatography for Characterization of Multiple Glycoprotein Biomarker Candidates in Serum from Breast Cancer Patients
2006
Femtomolar Detection of Prostate-Specific Antigen: An Immunoassay Based on Surface-Enhanced Raman Scattering and Immunogold Labels
2003
Surface-Enhanced Raman Spectroscopy for Bioanalysis: Reliability and Challenges
2018 Standout
Accuracy and the effect of possible subject‐based confounders of magnitude‐based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference
2015
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Intraepithelial CD8+tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
2005 Standout
New Electrochemiluminescent Immunoassay for the Determination of CYFRA 21-1: Analytical Evaluation and Clinical Diagnostic Performance in Urine Samples of Patients with Bladder Cancer
1999
Case–Control and Two-Gate Designs in Diagnostic Accuracy Studies
2005
Electrochemiluminescence (ECL)
2004 Standout
Does Aggressive Surgery Only Benefit Patients With Less Advanced Ovarian Cancer? Results From an International Comparison Within the SCOTROC-1 Trial
2005
Hepascore: An Accurate Validated Predictor of Liver Fibrosis in Chronic Hepatitis C Infection
2005
Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease☆
2007
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
PROGNOSTIC MARKERS IN BLADDER CANCER: A CONTEMPORARY REVIEW OF THE LITERATURE
1998
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers
2019
Nanostructures in Biodiagnostics
2005 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Antibody detection by agglutination–PCR (ADAP) enables early diagnosis of HIV infection by oral fluid analysis
2018 StandoutNobel
Flavylium Polymethine Fluorophores for Near‐ and Shortwave Infrared Imaging
2017 StandoutNobel
Works of Robert Thiel being referenced
Noninvasive Quantification of Hepatic Fat Content Using Three-Echo Dixon Magnetic Resonance Imaging With Correction for T2* Relaxation Effects
2011
Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen
1995
Serum HER2 extracellular domain in metastatic breast cancer patients treated with weekly trastuzumab and paclitaxel: association with HER2 status by immunohistochemistry and fluorescence in situ hybridization and with response rate
2005
Neoadjuvant Chemotherapy for Advanced Ovarian Cancer: Long-Term Survival
1999
Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies
2005
Serum markers detect the presence of liver fibrosis: A cohort study
2004
Urinary Nuclear Matrix Protein as a Marker for Transitional Cell Carcinoma of the Urinary Tract
1996
Fifth-Generation Digital Immunoassay for Prostate-Specific Antigen by Single Molecule Array Technology
2011
Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical Treatment
1996
Folate Receptor Alpha Expression in Lung Cancer: Diagnostic and Prognostic Significance
2012